{"ticker":"CVKD","name":"Cadrenal Therapeutics, Inc.","sector":"Nephrology","total_score":12.2,"grade":"F","components":{"insider_buy":0.0,"dilution_risk":0.74,"clinical_trial":0.0,"short_interest":0.1},"calculated_at":"2026-10-20 07:00:04.543112","latest_signals":[{"signal_type":"clinical_trial","score":0.0,"data":{"as_of":"2026-10-20","total":0,"phase1":0,"phase2":0,"phase3":0,"phase4":0,"source_type":"clinicaltrials.gov","source_url":"https://clinicaltrials.gov/","public_gate":"fresh_clinicaltrials_aggregate"},"created_at":"2026-10-20 03:33:24.958983"},{"signal_type":"dilution_risk","score":0.74,"data":{"float_risk":30,"risk_level":"HIGH","cash_runway":95,"description":"Dilution score: 74/100 (HIGH), 2.6 months cash","months_cash":2.6,"warrant_risk":40,"dilution_score":74,"convertible_risk":15,"offering_ability":72,"public_risk_label":"HIGH","score_limitations":[],"shares_outstanding":null,"outstanding_warrants":0.0,"source_type":"DilutionWatch SEC-derived score","source_url":"https://www.sec.gov/edgar/search/","public_gate":"fresh_dilutionwatch_score"},"created_at":"2026-10-20 06:02:37.511262"},{"signal_type":"insider_buy","score":0.5,"data":{"as_of":"2026-10-20","buy_count":5,"source_url":"https://www.sec.gov/edgar/search/","period_days":30,"source_type":"SEC EDGAR Form 4","filing_count":5,"total_shares":0,"share_count_available":false,"public_gate":"fresh_sec_form4_aggregate"},"created_at":"2026-10-20 08:00:35.461922"},{"signal_type":"short_interest","score":0.1,"data":{"trend":"DECREASING","change_pct":-10.82,"description":"Short interest: 4.45% of float, squeeze risk: LOW","squeeze_risk":"LOW","days_to_cover":1.08,"short_interest":105945,"short_pct_float":4.45,"source_type":"FINRA short interest","source_url":"https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data","public_gate":"fresh_finra_short_interest"},"created_at":"2026-10-19 18:26:07.808297"}],"signal_counts":{"clinical_trial":1,"dilution_risk":1,"insider_buy":1,"short_interest":30},"ticker_status":null}